As you will now be aware, some of DG-GT's activities have been affected by the COVID-19 pandemic. Further details are provided below, and we will continue to update you on the status of these activities as and when we have more information. Any changes or updates will be communicated as soon as possible via our website, mailing list and social media. We appreciate your patience and understanding during this uncertain time.
As a society, we wish to extend our thoughts and very best wishes to all of our members, supporters and community, including many who are re-focussing their efforts to contribute to the fight against COVID-19. We look forward to seeing you all at our events in the near future.
on behalf of the DG-GT Board
Annual Meeting Status Update
We are hoping to postpone the DG-GT Symposium to the beginning of 2021 and we are very keen to have it at the Herrenhausen Palace in Hannover in the exact same format. We are currently liaising with the Volkswagen Foundation to confirm venue availability and to make alternative arrangements. We will of course keep you informed.
DG-GT Outreach Programme
As announced a couple of weeks ago the DG-GT is launching an outreach programme, to support members who are organising outreach activities. Check our website for more details on this programme.
The ESGCT will be organising a series of educational and COVID-19 webinars with talks similar to those scheduled to take place at the ESGCT Spring School. More on this to follow next week or keep checking the website for a detailed schedule.
ASGCT 2020 Annual Meeting
ASGCT 2020 has gone virtual. If you are not yet registered, this might be your chance to take part to the ASGCT congress. With lower registration rates and no travel or accommodation costs, the ASGCT is promising to offer a complete congress with exhibition hall, numerous sessions and outstanding speakers. REGISTER AND VIEW PROGRAMME.
- Human Gene Therapy: Our journal, Human Gene Therapy, now has a Coronavirus web page dedicated to the virus research including some very interesting articles. VIEW HERE.
- Vaccine Clinical Trial: Our long term sponsor BioNTech has partnered with Pfizer to announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates. See more information in their press release.
Who's Who in Gene & Cell Therapy
DG-GT is involved in the development of a database of European gene and cell therapy organisations. Hosted on the ESGCT website, this online resource aims to promote awareness of organisations in the sector and foster collaborations between them.
Are you listed? View the database and submit your organisation's details HERE.
Tell us what you think! Your feedback will help us develop resources to best meet the needs of the European gene and cell therapy community. Complete the survey HERE and enter a prize draw where you could win up to a 50% discount on registration for the next ESGCT Annual Congress.
We would like to thank all the sponsors who are supporting our society.